Association of Hyperuricemia With Immune Disorders and Intestinal Barrier Dysfunction

Abstract

Hyperuricemia was characterized by dysregulated intestinal immunity, compromised intestinal barrier, and systemic inflammation. These findings might serve as a basis for future novel therapeutic interventions for hyperuricemia.